Donor pretreatment with methylprednisolone synergistically prolongs survival of cardiac allografts in sensitized rat recipients conditioned with rapamycin.
Schmidbauer
G
G
Department of Surgery, Justus-Liebig University, Giessen, Germany.
Homeyer
A
A
Bohle
R M
RM
Grimm
H
H
Binder
J
J
Kupiec-Weglinski
J W
JW
D000818:Animals; D006085:Graft Survival / Q000187:drug effects / Q000502:physiology*; D016027:Heart Transplantation / Q000276:immunology* / Q000502:physiology; D007074:Immunoglobulin G / Q000097:blood; D007075:Immunoglobulin M / Q000097:blood; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D007518:Isoantibodies / Q000097:blood; D007959:Lymphocyte Culture Test, Mixed; D008775:Methylprednisolone / Q000494:pharmacology*; D011090:Polyenes / Q000494:pharmacology*; D051381:Rats; D011914:Rats, Inbred BN; D011917:Rats, Inbred Lew; D020123:Sirolimus; D016038:Skin Transplantation / Q000276:immunology*; D014184:Transplantation, Homologous
D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007166:Immunosuppressive Agents; D007518:Isoantibodies; D011090:Polyenes; D020123:Sirolimus; D008775:Methylprednisolone